Terms: = Colorectal cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207
3732 results:
1. Remote ischemic preconditioning versus sham-control for prevention of anastomotic leakage after resection for rectal cancer (RIPAL trial): a pilot randomized controlled, triple-blinded monocenter trial.
Hardt J; Seyfried S; Brodrecht H; Khalil L; Büttner S; Herrle F; Reissfelder C; Rahbari NN
Int J Colorectal Dis; 2024 May; 39(1):65. PubMed ID: 38700747
[TBL] [Abstract] [Full Text] [Related]
2. Long non-coding RNA LOXL1-AS1: a potential biomarker and therapeutic target in human malignant tumors.
Fu XP; Ji CY; Tang WQ; Yu TT; Luo L
Clin Exp Med; 2024 May; 24(1):93. PubMed ID: 38693424
[TBL] [Abstract] [Full Text] [Related]
3. Exploring the Key Signaling Pathways and ncRNAs in colorectal cancer.
Lee YJ; Kim WR; Park EG; Lee DH; Kim JM; Shin HJ; Jeong HS; Roh HY; Kim HS
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674135
[TBL] [Abstract] [Full Text] [Related]
4. Ginsenoside Rg1 Induces Autophagy in colorectal cancer through Inhibition of the akt/mTOR/p70S6K Pathway.
Liu R; Zhang B; Zou S; Cui L; Lin L; Li L
J Microbiol Biotechnol; 2024 Apr; 34(4):774-782. PubMed ID: 38668684
[TBL] [Abstract] [Full Text] [Related]
5. Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experience.
Moretto R; Germani MM; Borelli B; Conca V; Rossini D; Boraschi P; Donati F; Urbani L; Lonardi S; Bergamo F; Cerma K; Ramondo G; D'Amico FE; Salvatore L; Valente G; Barbaro B; Giuliante F; Di Maio M; Masi G; Cremolini C
ESMO Open; 2024 Apr; 9(4):102991. PubMed ID: 38631269
[TBL] [Abstract] [Full Text] [Related]
6. BET inhibition induces synthetic lethality in PTEN deficient colorectal cancers via dual action on p21
Ren G; Chen J; Pu Y; Yang EJ; Tao S; Mou PK; Chen LJ; Zhu W; Chan KL; Luo G; Deng C; Shim JS
Int J Biol Sci; 2024; 20(6):1978-1991. PubMed ID: 38617536
[TBL] [Abstract] [Full Text] [Related]
7. PREX2 contributes to radiation resistance by inhibiting radiotherapy-induced tumor immunogenicity via cGAS/STING/IFNs pathway in colorectal cancer.
Li M; Xiao J; Song S; Han F; Liu H; Lin Y; Ni Y; Zeng S; Zou X; Wu J; Wang F; Xu S; Liang Y; Xu P; Hong H; Qiu J; Cao J; Zhu Q; Liang L
BMC Med; 2024 Apr; 22(1):154. PubMed ID: 38609982
[TBL] [Abstract] [Full Text] [Related]
8. Discovery of a novel small-molecule activator of SIRT3 that inhibits cell proliferation and migration by apoptosis and autophagy-dependent cell death pathways in colorectal cancer.
Mou Y; Chen Y; Fan Z; Ye L; Hu B; Han B; Wang G
Bioorg Chem; 2024 May; 146():107327. PubMed ID: 38579616
[TBL] [Abstract] [Full Text] [Related]
9. Synergistic targeting of TrxR1 and ATM/akt pathway in human colon cancer cells.
Shen X; Xia Y; Lu H; Zheng P; Wang J; Chen Y; Xu C; Qiu C; Zhang Y; Xiao Z; Zou P; Cui R; Ni D
Biomed Pharmacother; 2024 May; 174():116507. PubMed ID: 38565059
[TBL] [Abstract] [Full Text] [Related]
10. Indoxyl sulfate contributes to colorectal cancer cell proliferation and increased EGFR expression by activating AhR and akt.
Ichisaka Y; Yano S; Nishimura K; Niwa T; Shimizu H
Biomed Res; 2024; 45(2):57-66. PubMed ID: 38556263
[TBL] [Abstract] [Full Text] [Related]
11. Predictive value of immediate early response 5 like (IER5L) in the prognosis and immune checkpoint blockade therapy of non-small cell lung cancer patients.
Wang N; Tan X; Cao S; Liu M
Pathol Res Pract; 2024 Apr; 256():155270. PubMed ID: 38552564
[TBL] [Abstract] [Full Text] [Related]
12. PI3K/akt/mTOR Signaling Pathway as a Target for colorectal cancer Treatment.
Leiphrakpam PD; Are C
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542151
[TBL] [Abstract] [Full Text] [Related]
13. Timing of Surgery and Social Determinants of Health Related to Pathologic Complete Response after Total Neoadjuvant Therapy for Rectal Adenocarcinoma: Retrospective Study of National cancer Database.
Mai M; Goldman J; Appiah D; Abdulrahman R; Kidwell J; Shi Z
Curr Oncol; 2024 Feb; 31(3):1291-1301. PubMed ID: 38534930
[TBL] [Abstract] [Full Text] [Related]
14. Reduced chemokine C-C motif ligand 1 expression may negatively regulate colorectal cancer progression at liver metastatic sites.
Iwata M; Haraguchi R; Kitazawa R; Ito C; Ogawa K; Takada Y; Kitazawa S
J Cell Mol Med; 2024 Apr; 28(7):e18193. PubMed ID: 38506205
[TBL] [Abstract] [Full Text] [Related]
15. Prognosis significance and potential association between ALDOA and akt expression in colorectal cancer.
Xu M; Xi S; Li H; Xia Y; Mei G; Cheng Z
Sci Rep; 2024 Mar; 14(1):6488. PubMed ID: 38499636
[TBL] [Abstract] [Full Text] [Related]
16. Inhibition of PI3K/akt signaling using BKM120 reduced the proliferation and migration potentials of colorectal cancer cells and enhanced cisplatin-induced cytotoxicity.
Khameneh SC; Sari S; Razi S; Yousefi AM; Bashash D
Mol Biol Rep; 2024 Mar; 51(1):420. PubMed ID: 38483663
[TBL] [Abstract] [Full Text] [Related]
17. Inhibition of Multifunctional Protein p32/C1QBP Promotes Cytostatic Effects in Colon cancer Cells by Altering Mitogenic Signaling Pathways and Promoting Mitochondrial Damage.
Egusquiza-Alvarez CA; Moreno-Londoño AP; Alvarado-Ortiz E; Ramos-Godínez MDP; Sarabia-Sánchez MA; Castañeda-Patlán MC; Robles-Flores M
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473963
[TBL] [Abstract] [Full Text] [Related]
18. Role of deubiquitinase JOSD2 in the pathogenesis of esophageal squamous cell carcinoma.
Wang WP; Shi D; Yun D; Hu J; Wang JF; Liu J; Yang YP; Li MR; Wang JF; Kong DL
World J Gastroenterol; 2024 Feb; 30(6):565-578. PubMed ID: 38463028
[TBL] [Abstract] [Full Text] [Related]
19. [LncRNA SNHG11 promotes malignant progression of colorectal cancer cells through the PI3K/akt/mTOR signaling pathway].
Tao SN; Liu XC; Wang YY; Yang H
Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):758-765. PubMed ID: 38462356
[No Abstract] [Full Text] [Related]
20. Regulation of metastatic potential by drug repurposing and mitochondrial targeting in colorectal cancer cells.
Mathur S; Srivastava P; Srivastava A; Rai NK; Abbas S; Kumar A; Tiwari M; Sharma LK
BMC Cancer; 2024 Mar; 24(1):323. PubMed ID: 38459456
[TBL] [Abstract] [Full Text] [Related]
[Next]
